The respiratory virus HMPV uses its fusion (F) protein – which interacts with cellular receptors called integrins – to bind to and enter target cells.

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.

Dysfunction or loss of an “antioxidant” enzyme may lead to higher risk for esophageal cancer in patients with gastric reflux disease.

Socioeconomic factors, African ancestry linked to risk for cancer-causing infection.

Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors.

MicroRNA “regulatory networks” generated at Vanderbilt aid search for biomarkers and new drugs to treat glioblastoma, the most common and lethal primary brain tumor.

A protein linked to aggressive bladder cancers could point to new strategies for treatment or prevention.